Status:
RECRUITING
Electroporation vs. Radiofrequency Ablation Guided by 3D Imaging in Repeat Procedures for Atrial Fibrillation
Lead Sponsor:
Wroclaw Medical University
Conditions:
Atrial Fibrillation (AF)
Ablation Techniques
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a prospective, randomized clinical trial evaluating the efficacy and safety of two techniques for repeat catheter ablation in patients with recurrent atrial fibrillation (AF): thermal energy a...
Detailed Description
Background Atrial fibrillation (AF) is one of the most common cardiac arrhythmias, with a lifetime risk of approximately 30% in individuals over 55 years of age. A primary treatment option for AF is p...
Eligibility Criteria
Inclusion
- Documented recurrence of AF or atypical atrial flutter after prior PVI Eligibility for re-PVI
Exclusion
- Left ventricular ejection fraction \< 30% Left atrial volume index (LAVI) \> 72 mL/m² Untreated hyperthyroidism Hypertrophic cardiomyopathy Severe valvular heart disease
Key Trial Info
Start Date :
August 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT07141745
Start Date
August 30 2025
End Date
October 1 2028
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Department of Cardio, Jan Mikulicz Radecki University Hospital in Wroclaw
Wroclaw, Poland, 50-556